3eff S.A.
  • Home
  • About us
  • Products
    • 3mec
    • 3val
  • Services
    • Clinical
    • Economy
  • Publications
  • Contact us
  • Esp
  • Eng
  • Menu Menu
  • LinkedIn
  • Twitter
  • Instagram

Unveiling the Fiscal Burden of Migraine in Argentina

10/11/2024/in Publications /by T S
https://3eff.com/wp-content/uploads/3eff_logoOK.png 0 0 T S https://3eff.com/wp-content/uploads/3eff_logoOK.png T S2024-11-10 14:27:132025-07-10 14:34:28Unveiling the Fiscal Burden of Migraine in Argentina

Budget-Impact Analysis of Encorafenib Plus Binimetinib as a Treatment for Advanced NSCLC With BRAFV600-Mutation in Older Adults From Argentina

01/11/2024/in Publications /by adm1n
https://3eff.com/wp-content/uploads/3eff_logoOK.png 0 0 adm1n https://3eff.com/wp-content/uploads/3eff_logoOK.png adm1n2024-11-01 16:24:212025-07-10 14:21:13Budget-Impact Analysis of Encorafenib Plus Binimetinib as a Treatment for Advanced NSCLC With BRAFV600-Mutation in Older Adults From Argentina

Budget Impact Analysis of Oral Treatment With Nirmaltrevir+Ritonavir for COVID-19 in Argentina

01/11/2023/in Publications /by T S
https://3eff.com/wp-content/uploads/3eff_logoOK.png 0 0 T S https://3eff.com/wp-content/uploads/3eff_logoOK.png T S2023-11-01 01:00:332025-07-16 14:39:37Budget Impact Analysis of Oral Treatment With Nirmaltrevir+Ritonavir for COVID-19 in Argentina

3EFF S.A.
© Copyright 2021

  • Design & development: tribytes.com
Scroll to top